Actionable targets to reduce COVID-19 severity

Identifying mechanistic pathways that link obesity with COVID-19 severity provides targets for interventions to reduce the high risk of severe outcomes owing to obesity. The authors of a recent study use genomics and proteomics to show that nephronectin could be involved in one of these pathways.

Automated summary

Identifying mechanistic pathways that link obesity with COVID-19 severity provides targets for interventions to reduce the high risk of severe outcomes owing to obesity. The authors of a recent study use genomics and proteomics to show that nephronectin could be involved in one of these pathways.